Imperative Care, Inc. v. Inari Medical, Inc. et al.

IPR2025-00989

Imperative Care’s petition to invalidate Inari Medical’s hemostasis valve patent was granted. The Board found a reasonable likelihood of success on anticipation and obviousness grounds and instituted review of all nine claims.

Jurisdiction
US PTAB
Case Number
IPR2025-00989
Judge(s)
Jeffrey N. Fredman, Eric C. Jeschke, Timothy G. Majors
Decision Date
5 September 2025

Detailed Summary

In an inter partes review decision dated January 23, 2025, the Patent Trial and Appeal Board granted Imperative Care’s petition to institute review of Inari Medical’s U.S. Patent No. 11,697,011 covering hemostasis valves for minimally invasive surgery. The petitioner asserted five grounds of unpatentability, invoking 35 U.S.C. §§ 102 and 103, relying on prior art references Schaffer, Hartley, and Eller. The Board concluded that the petitioner demonstrated a reasonable likelihood of prevailing, particularly on anticipation of claim 1 by Schaffer, and therefore instituted the trial on all nine challenged claims. No claim constructions were finalized, and the matter proceeds to trial.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Imperative Care, Inc. vs Inari Medical, Inc. et al. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentPGR2026-00042

Wealth, Inc.vs--

Wealth, Inc. has filed a Post‑Grant Review petition seeking cancellation of all 20 claims of Vanilla Technologies’ U.S. Patent 12,353,917, alleging ineligibility, obviousness, indefiniteness, and an improper dependent claim. The petition relies on prior‑art references Racanelli, Bateman, Dintenfass, McMillen and Kwak.

patentIPR2026-00325

Microsoft CorporationvsQomplx LLC

Microsoft has filed an IPR petition challenging 16 claims of Qomplx’s U.S. Patent 12,301,627 covering graph‑based network anomaly detection. The challenger asserts obviousness over prior‑art references Stokes, Crabtree, and Sekar under 35 U.S.C. §103.

patentIPR2026-00297

Microsoft CorporationvsToutVirtual, Inc.

Microsoft has filed an IPR petition challenging all 20 claims of ToutVirtual’s ‘667 patent covering virtual system management, asserting obviousness over multiple prior‑art references.

patentIPR2026-00187

Cisco Systems, Inc.vsGOLDEN EYE TECHNOLOGIES LLC

Cisco has filed an IPR petition seeking to invalidate claims 1‑3 and 13‑15 of Golden Eye Technologies' 9,717,037 patent. The challenger argues the claims are obvious over earlier Wi‑Fi standards and patents (Choudhary, Hasty, Chen). The petition requests the Board to institute the review and cancel the challenged claims.

patentIPR2026-00186

Cisco Systems, Inc.vsGolden Eye Technologies LLC

Cisco has filed an IPR petition seeking to invalidate claims 1‑4 and 9‑11 of Golden Eye’s ’556 Wi‑Fi scanning patent, arguing that the claims are obvious over three earlier patents. The petition emphasizes that the patent was allowed despite acknowledging the same prior‑art concepts.

patentIPR2026-00334

Pinterest, Inc.vs--

Pinterest has filed an IPR petition challenging all 20 claims of OpenTV’s ’703 patent, asserting that the claims are obvious over prior art such as Orr, Hsu, Lim, and Hervey.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call